Peptide News Digest

#Ai-Peptide-Design

2 stories

Research · View digest

bioRxiv (May 1): Generative AI Designs Peptides with Custom Secondary Structure Motifs Using Reduced Amino-Acid Alphabets

A May 1 bioRxiv preprint introduces a generative AI protein-design model trained on hundreds of thousands of structures from the RCSB PDB to produce peptides with custom secondary structure motifs while operating on reduced amino-acid alphabets. The work targets a real bottleneck in cyclic peptide drug development — generating sequences that fold into specified secondary-structure scaffolds without exhausting the full 20-letter design space, which lowers the barrier for synthesis and downstream maturation. It joins the recent University of Utah PapB enzymatic cyclization paper, the Nature Communications few-shot AI Acinetobacter pipeline, and Profluent's recombinase work as part of the broader AI-peptide-design wave through April–May 2026.

Research · View digest

PLOS Computational Biology: MsgaBpred Model Improves B-Cell Epitope Prediction for Vaccine and Diagnostic Peptide Design

A PLOS Computational Biology paper published April 28 introduced MsgaBpred, a multi-scale graph attention model for predicting B-cell epitopes — short peptide sequences recognized by antibodies. The model achieved high accuracy on cross-species benchmarks and is directly relevant for peptide vaccine antigen design, diagnostic peptide development, and antibody-target discovery. The work joins the broader 2026 wave of AI-driven peptide tooling, complementing the Nature Communications DDA-BERT and CycloSEL papers from earlier in the month.